Affiliation: Merck Research Laboratories
- Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella diseaseP Coplan
Merck Research Laboratories, Blue Bell, PA 19422, USA
Pediatr Infect Dis J 20:641-5. 2001..We report on a baseline assessment of the age-specific incidence and hospitalization rates of varicella and herpes zoster that was conducted before vaccine introduction...
- Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitorsPaul M Coplan
Department of Epidemiology, Merck Research Laboratories, West Point, Pennsylvania 19486, USA
AIDS Res Hum Retroviruses 19:449-55. 2003..Although studies with a longer duration of PI therapy are in progress to assess whether a later increase in MI incidence occurs, our analysis did not demonstrate a dramatic increase in MI risk during the first year of PI therapy...
- Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trialJ Cook
Merck and Co, Inc, Whitehouse Station, New Jersey 08889, USA
AIDS Res Hum Retroviruses 15:499-508. 1999..At 20 years, the incremental cost per life-year gained by adding IDV to a ZDV+3TC regimen was estimated at $13,229, which is well within the range of other widely accepted medical interventions...
- Fat redistribution in indinavir-treated patients with HIV infection: A review of postmarketing casesJ O Benson
Merck and Company, Inc, West Point, Pennsylvania, USA
J Acquir Immune Defic Syndr 25:130-9. 2000....
- Epidemiology of bacterial meningitis among children in Brazil, 1997-1998D P Weiss
Department of Epidemiology, Merck Sharp and Dohme Research Laboratories, West Point, Pennsylvania, USA
Rev Saude Publica 35:249-55. 2001....